40 
“(ii) the monitoring systems which may include 
periodic health screening to protect against accidental 
exposure or accidental exposure and other hazards to the 
health of all personnel who may he affected in such ac- 
tivities . and 
“(mj the type and form, of information to he given to 
such personnel concerning the nature of the health risks 
involved in such activities; 
“(B) prescribe requirements respecting — 
“(i) the maintenance of a register at a licensed facility 
which shall include the names, addresses and health rec- 
ords of persons exposed to recombinant DXA in connec- 
tion with the licensed facility: and 
“(ii) the monitoring hy the person who owns or op- 
erates the facility of the health of each such person; 
“(C) prescribe requirements respecting the establishment , 
functions, arid operations of Institutional Biohazard Review 
Committees affiliated with each facility licensed pursuant to 
section 1803. Such regulations shall contain requirements — 
“(i) prescribing that the composition of the members 
on such committees be as follows — 
“(I) at least one-third of the total members be 
individuals — 
“(a) who are not and have never been pro- 
fessionally engaged in biological research ; 
“(b) who are qualified to serve as members 
of the general public including persons who by 
virtue of their training, experience or back- 
ground in the fields of medicine, law. ethics, ed- 
ucation .. . physical, behavioral and social sciences , 
philosophy, humanities, health administration , 
government, or public affairs: 
“(c) who have no financial interest in recom- 
binant DXA activities and who are not employ- 
ees of the owners or operators of such facility or 
of persons who hare a financial interest ; and 
“ ( d) who are residents of a local community 
which is proximate to the facility: and 
“(II) uf. least another one-third of the total members 
be individuals — 
“(o) who are employees of the owners or opera- 
tors of the facility; and 
“(b) who axe qualified through their expertise and 
training to provide a diversity of viewpoints rele- 
vant to rer-ombinant DXA activities and technology . 
bioloaicol safety and engineering, and biohazard 
monitoring. 
“(ii) providing for the review and approval by such com- 
mittees of all recombinant DXA projects to be undertaken by 
a facility licensed under section 1803. Such review and ap- 
proval shall include the adequacy of the containment level 
and the safety of the procedures contemplated to assure com- 
pliance with the requirements of this title. 
[ 780 ] 
